Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hay

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Antiviral Therapy|June 11, 2014
A randomized study of standard versus double dose oseltamivir for treating influenza in the communityRashmi Dixit, Gulam Khandaker, Peter Hay, et al.
American Heart Journal|October 5, 2020
Ultra-low-dose quadruple combination blood pressure-lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocolClara K Chow, Emily R Atkins, Laurent Billot, et al.
Journal of Hypertension|March 19, 2024
Ambulatory blood pressure after 12 weeks of quadruple combination of quarter doses of blood pressure medication vs. standard medicationJanis M Nolde, Emily Atkins, Simone Marschner, et al.
Journal of Human Hypertension|May 14, 2024
Participants' views of ultra-low dose combination therapy for high blood pressure: a mixed-methods study from the QUARTET trialJoshua G Kovoor, Clara K Chow, Abdul Salam, et al.
Lancet (London, England)|September 1, 2021
Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trialClara K Chow, Emily R Atkins, Graham S Hillis, et al.
Heart (British Cardiac Society)|August 8, 2023
Cost-effectiveness of ultra-low-dose quadruple combination therapy for high blood pressureEmily R Atkins, Alexander Chye, Thomas Lung, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Antiviral Therapy|June 11, 2014
A randomized study of standard versus double dose oseltamivir for treating influenza in the communityRashmi Dixit, Gulam Khandaker, Peter Hay, et al.
American Heart Journal|October 5, 2020
Ultra-low-dose quadruple combination blood pressure-lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocolClara K Chow, Emily R Atkins, Laurent Billot, et al.
Journal of Hypertension|March 19, 2024
Ambulatory blood pressure after 12 weeks of quadruple combination of quarter doses of blood pressure medication vs. standard medicationJanis M Nolde, Emily Atkins, Simone Marschner, et al.
Journal of Human Hypertension|May 14, 2024
Participants' views of ultra-low dose combination therapy for high blood pressure: a mixed-methods study from the QUARTET trialJoshua G Kovoor, Clara K Chow, Abdul Salam, et al.
Lancet (London, England)|September 1, 2021
Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trialClara K Chow, Emily R Atkins, Graham S Hillis, et al.
Heart (British Cardiac Society)|August 8, 2023
Cost-effectiveness of ultra-low-dose quadruple combination therapy for high blood pressureEmily R Atkins, Alexander Chye, Thomas Lung, et al.
Pageof 1